In Vivo Validation of the Mutant Selection Window Hypothesis with Moxifloxacin in a Murine Model of Tuberculosis

Tekijä Almeida, Deepak, Nuermberger, Eric, Tyagi, Sandeep, Bishai, William R., Grosset, Jacques
Julkaistu 2007

BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse

Tekijä Converse, Paul J., Almeida, Deepak V., Nuermberger, Eric L., Grosset, Jacques H.
Julkaistu 2011

Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Tekijä Converse, Paul J, Nuermberger, Eric L, Almeida, Deepak V, Grosset, Jacques H
Julkaistu 2011

Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?

Tekijä Rosenthal, Ian M., Zhang, Ming, Almeida, Deepak, Grosset, Jacques H., Nuermberger, Eric L.
Julkaistu 2008

Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay

Tekijä Converse, Paul J., Almeida, Deepak V., Tyagi, Sandeep, Xu, Jian, Nuermberger, Eric L.
Julkaisussa Antimicrob Agents Chemother (2019)

Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis

Tekijä Nuermberger, Eric, Tyagi, Sandeep, Tasneen, Rokeya, Williams, Kathy N., Almeida, Deepak, Rosenthal, Ian, Grosset, Jacques H.
Julkaistu 2008

Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis

Tekijä Almeida, Deepak, Nuermberger, Eric, Tasneen, Rokeya, Rosenthal, Ian, Tyagi, Sandeep, Williams, Kathy, Peloquin, Charles, Grosset, Jacques
Julkaistu 2009

Activities of Rifampin, Rifapentine and Clarithromycin Alone and in Combination against Mycobacterium ulcerans Disease in Mice

Tekijä Almeida, Deepak, Converse, Paul J., Ahmad, Zahoor, Dooley, Kelly E., Nuermberger, Eric L., Grosset, Jacques H.
Julkaistu 2011

Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy

Tekijä Andréjak, Claire, Almeida, Deepak V., Tyagi, Sandeep, Converse, Paul J., Ammerman, Nicole C., Grosset, Jacques H.
Julkaistu 2013

Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor

Tekijä Gupta, Shashank, Tyagi, Sandeep, Almeida, Deepak V., Maiga, Mariama C., Ammerman, Nicole C., Bishai, William R.
Julkaistu 2013

Characterization of Mouse Models of Mycobacterium avium Complex Infection and Evaluation of Drug Combinations

Tekijä Andréjak, Claire, Almeida, Deepak V., Tyagi, Sandeep, Converse, Paul J., Ammerman, Nicole C., Grosset, Jacques H.
Julkaisussa Antimicrob Agents Chemother (2015)

Using Bioluminescence To Monitor Treatment Response in Real Time in Mice with Mycobacterium ulcerans Infection

Tekijä Zhang, Tianyu, Li, Si-Yang, Converse, Paul J., Almeida, Deepak V., Grosset, Jacques H., Nuermberger, Eric L.
Julkaistu 2011

Bactericidal Activity Does Not Predict Sterilizing Activity: The Case of Rifapentine in the Murine Model of Mycobacterium ulcerans Disease

Tekijä Almeida, Deepak V., Converse, Paul J., Li, Si-Yang, Tyagi, Sandeep, Nuermberger, Eric L., Grosset, Jacques H.
Julkaistu 2013

Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model

Tekijä Almeida, Deepak V., Converse, Paul J., Omansen, Till F., Tyagi, Sandeep, Tasneen, Rokeya, Kim, Jeongjun, Nuermberger, Eric L.
Julkaisussa Antimicrob Agents Chemother (2020)

Microbiological, Histological, Immunological, and Toxin Response to Antibiotic Treatment in the Mouse Model of Mycobacterium ulcerans Disease

Tekijä Sarfo, Fred Stephen, Converse, Paul J., Almeida, Deepak V., Zhang, Jihui, Robinson, Clive, Wansbrough-Jones, Mark, Grosset, Jacques H.
Julkaistu 2013

Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis

Tekijä Almeida, Deepak, Ioerger, Thomas, Tyagi, Sandeep, Li, Si-Yang, Mdluli, Khisimuzi, Andries, Koen, Grosset, Jacques, Sacchettini, Jim, Nuermberger, Eric
Julkaisussa Antimicrob Agents Chemother (2016)

Combination Chemotherapy with the Nitroimidazopyran PA-824 and First-Line Drugs in a Murine Model of Tuberculosis

Tekijä Nuermberger, Eric, Rosenthal, Ian, Tyagi, Sandeep, Williams, Kathy N., Almeida, Deepak, Peloquin, Charles A., Bishai, William R., Grosset, Jacques H.
Julkaistu 2006

Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis

Tekijä Xu, Jian, Tasneen, Rokeya, Peloquin, Charles A., Almeida, Deepak V., Li, Si-Yang, Barnes-Boyle, Kala, Lu, Yu, Nuermberger, Eric
Julkaisussa Antimicrob Agents Chemother (2017)

Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer

Tekijä Almeida, Deepak V., Omansen, Till F., Li, Si-Yang, Lee, Jin, Grosset, Jacques H., Converse, Paul J., Nuermberger, Eric L.
Julkaisussa Antimicrob Agents Chemother (2019)

Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice

Tekijä Almeida, Deepak V., Tyagi, Sandeep, Li, Si-Yang, Wallengren, Kristina, Pym, Alexander S., Ammerman, Nicole C., Bishai, William R., Grosset, Jacques H.
Julkaisussa Mycobact Dis (2014)